Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy.
Ito
T
T
Shibata
K
K
Watanabe
A
A
Akabane
J
J
D000293:Adolescent; D000547:Amantadine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy*; D018492:Dopamine Antagonists / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D000998:Antiviral Agents; D018492:Dopamine Antagonists; D000547:Amantadine